₹ 3.5 Cr
Volume Transacted
(Dec 4, 2024)
19.6 K
Stocks Traded
(Dec 4, 2024)
Last Updated on: Dec 04, 2024
Sun Pharmaceuticals Industries Ltd
NSE: SUNPHARMA
ISIN
INE044A01036
Last updated on: Dec 04, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Sun Pharmaceuticals Industries Ltd
NSE: SUNPHARMA
Share Price
₹ 1800.05
1.45 (0.08%)
Last updated on: Dec 04, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
04 Dec 2024 | 1800.05 | 1811.95 | 1812 | 1785.55 |
03 Dec 2024 | 1798.6 | 1823.6 | 1830 | 1789.1 |
02 Dec 2024 | 1808.2 | 1800.15 | 1814.35 | 1790.3 |
29 Nov 2024 | 1781.65 | 1740.2 | 1795.55 | 1739.15 |
28 Nov 2024 | 1735.15 | 1755 | 1760 | 1723.65 |
27 Nov 2024 | 1749.5 | 1761.95 | 1777.35 | 1741 |
26 Nov 2024 | 1759.95 | 1804.7 | 1805.9 | 1754 |
25 Nov 2024 | 1804.65 | 1819.35 | 1826.1 | 1784.5 |
22 Nov 2024 | 1797.8 | 1789.5 | 1815.65 | 1768 |
21 Nov 2024 | 1777.65 | 1778.25 | 1791.3 | 1759.4 |
Date | Price (₹) |
---|---|
04 Dec 2024 | 1800.05 |
03 Dec 2024 | 1798.6 |
02 Dec 2024 | 1808.2 |
29 Nov 2024 | 1781.65 |
28 Nov 2024 | 1735.15 |
27 Nov 2024 | 1749.5 |
26 Nov 2024 | 1759.95 |
25 Nov 2024 | 1804.65 |
22 Nov 2024 | 1797.8 |
21 Nov 2024 | 1777.65 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Dr Reddys Laboratories Ltd | INE089A01031 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Dr Reddys Laboratories Ltd | INE089A01031 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Last updated time: 04 Dec 9.00 AM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Sun Pharmaceuticals Industries Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Sun Pharmaceuticals Industries Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Sun Pharma tumbles after US court halts Leqselvi launch
Aa result of the court's decision, Sun Pharma has been temporarily barred from launching L...
04 Nov 2024 11:14
Sun Pharmaceuticals Industries Ltd up for third straight session
Sun Pharmaceuticals Industries Ltd is up for a third straight session today. The stock is ...
28 Oct 2024 13:05
Sun Pharma gains after Q2 PAT climbs 28% YoY to Rs 3,040 cr
Profit before tax was at Rs 3,597.88 crore in Q2 FY25, registering a growth of 28.91% on Y...
28 Oct 2024 16:01
Sun Pharmaceuticals Industries to hold board meeting
Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Compan...
09 Oct 2024 17:30
Sun Pharma inks global licensing agreement with Philogen
Sun Pharmaceutical Industries and Philogen S.p.A (Philogen) today announced that they have...
01 Oct 2024 10:34
Sun Pharma inks exclusive pact with Philogen for commercializing anti-cancer drug Fibromun
Philogen is an Italian-Swiss company active in the biotechnology sector, specialized in th...
01 Oct 2024 10:34
Unlimited trading starting at just Rs. 249*